# OnCo record paper-embark-nejm-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-embark-nejm-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-embark-nejm-2023" ;
  schema:name "EMBARK: enzalutamide with or without leuprolide in high-risk biochemically recurrent prostate cancer"@en ;
  schema:description "In men whose PSA was rising fast after surgery or radiotherapy without visible metastases, enzalutamide with or without hormone injections delayed metastases by years compared with hormone injections alone, with treatment paused when the PSA fell to undetectable."@en ;
  schema:url <https://onco.cc/key-papers/paper-embark-nejm-2023/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2303974>, <https://pubmed.ncbi.nlm.nih.gov/37851874/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2303974> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Freedland SJ, de Almeida Luz M, De Giorgi U, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate-bcr/> ;
  onco:drugs <https://onco.cc/drugs/enzalutamide/> ;
  onco:trials <https://onco.cc/trials/embark/> ;
  onco:journals <https://onco.cc/journals/nejm/> .